PRR27
gene geneOn this page
Summary
PRR27 (proline rich 27, HGNC:33193) is a protein-coding gene on chromosome 4q13.3, encoding Proline-rich protein 27 (Q6MZM9).
Located in extracellular exosome.
Source: NCBI Gene 401137 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 47 total
- MANE Select transcript:
NM_214711
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:33193 |
| Approved symbol | PRR27 |
| Name | proline rich 27 |
| Location | 4q13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000187533 |
| Ensembl biotype | protein_coding |
| Entrez | 401137 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 2 protein_coding, 2 nonsense_mediated_decay, 1 protein_coding_CDS_not_defined
ENST00000344526, ENST00000502294, ENST00000502441, ENST00000509633, ENST00000512173
RefSeq mRNA: 1 — MANE Select: NM_214711
NM_214711
CCDS: CCDS3535
Canonical transcript exons
ENST00000344526 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001399806 | 70162695 | 70166609 |
| ENSE00001547212 | 70154237 | 70154426 |
| ENSE00003500115 | 70156054 | 70156077 |
| ENSE00003518258 | 70161586 | 70161630 |
| ENSE00003641958 | 70158328 | 70158900 |
Expression profiles
Bgee: expression breadth broad, 26 present calls, max score 78.26.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 12.5765 / max 14854.7438, expressed in 15 samples.
FANTOM5 promoters (9 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 47884 | 11.1172 | 9 |
| 47883 | 0.8832 | 4 |
| 47882 | 0.2916 | 4 |
| 47886 | 0.0903 | 3 |
| 47892 | 0.0621 | 6 |
| 47885 | 0.0551 | 3 |
| 47893 | 0.0438 | 5 |
| 47891 | 0.0174 | 3 |
| 47890 | 0.0159 | 3 |
Top tissues by expression
118 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.26 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 69.82 | gold quality |
| minor salivary gland | UBERON:0001830 | 66.88 | gold quality |
| testis | UBERON:0000473 | 61.56 | gold quality |
| left testis | UBERON:0004533 | 61.09 | gold quality |
| right testis | UBERON:0004534 | 59.92 | gold quality |
| tonsil | UBERON:0002372 | 59.69 | gold quality |
| placenta | UBERON:0001987 | 48.45 | gold quality |
| bone marrow cell | CL:0002092 | 48.35 | gold quality |
| bone marrow | UBERON:0002371 | 47.41 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 43.14 | silver quality |
| ventricular zone | UBERON:0003053 | 40.28 | silver quality |
| muscle tissue | UBERON:0002385 | 39.33 | silver quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 39.10 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ganglionic eminence | UBERON:0004023 | 37.15 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| sural nerve | UBERON:0015488 | 36.38 | gold quality |
| urinary bladder | UBERON:0001255 | 34.99 | gold quality |
| monocyte | CL:0000576 | 34.86 | gold quality |
| leukocyte | CL:0000738 | 34.20 | gold quality |
| duodenum | UBERON:0002114 | 32.48 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| blood | UBERON:0000178 | 30.77 | gold quality |
| primary visual cortex | UBERON:0002436 | 30.04 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| islet of Langerhans | UBERON:0000006 | 29.74 | silver quality |
| right uterine tube | UBERON:0001302 | 29.66 | gold quality |
| pancreas | UBERON:0001264 | 28.94 | gold quality |
| muscle of leg | UBERON:0001383 | 28.93 | silver quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 2.65 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
183 targeting PRR27, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-4531 | 99.99 | 69.70 | 3181 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-196A-1-3P | 99.99 | 72.15 | 2772 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-8068 | 99.98 | 73.85 | 2376 |
| HSA-MIR-27A-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-27B-3P | 99.98 | 72.13 | 2955 |
| HSA-MIR-9985 | 99.98 | 72.11 | 2939 |
| HSA-MIR-4789-5P | 99.98 | 70.76 | 2721 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-485-3P | 99.98 | 70.68 | 1585 |
| HSA-MIR-539-3P | 99.98 | 70.74 | 1616 |
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Prr27 | ENSMUSG00000002240 |
Protein
Protein identifiers
Proline-rich protein 27 — Q6MZM9 (reviewed: Q6MZM9)
All UniProt accessions (3): D6RGD6, H0Y8Q8, Q6MZM9
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Secreted.
RefSeq proteins (1): NP_999876* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR033533 | PRR27 | Family |
UniProt features (7 total): sequence variant 2, signal peptide 1, chain 1, region of interest 1, compositionally biased region 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6MZM9-F1 | 54.70 | 0.05 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 46 (showing top):
chr4q13, CHAF1B_TARGET_GENES, HMGA1_TARGET_GENES, SNAI1_TARGET_GENES, MIR153_5P, MIR8485, MIR616_5P, MIR371B_5P, MIR373_5P, MIR651_3P, MIR4262, MIR4698, MIR6809_3P, MIR181A_5P_MIR181B_5P, MIR181D_5P
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (2): extracellular exosome (GO:0070062), extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| extracellular vesicle | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
272 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PRR27 | C4orf36 | Q96KX1 | 630 |
| PRR27 | STATH | P02808 | 573 |
| PRR27 | FDCSP | Q8NFU4 | 570 |
| PRR27 | CABS1 | Q96KC9 | 543 |
| PRR27 | ZG16B | Q96DA0 | 540 |
| PRR27 | ODAM | A1E959 | 507 |
| PRR27 | CFAP299 | Q6V702 | 462 |
| PRR27 | CST1 | P01037 | 430 |
| PRR27 | IGKV2-28 | A0A075B6P5 | 419 |
| PRR27 | KRT83 | P78385 | 394 |
| PRR27 | CSN1S1 | P47710 | 380 |
| PRR27 | ODAPH | Q17RF5 | 376 |
| PRR27 | NSUN5 | Q96P11 | 358 |
| PRR27 | PRB3 | Q04118 | 352 |
| PRR27 | CST5 | P28325 | 348 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| PRR27 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| TIMM10 | IGLL5 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (20): NUDT12 (Affinity Capture-MS), IDE (Affinity Capture-MS), CACNG6 (Affinity Capture-MS), SQSTM1 (Affinity Capture-MS), HECTD3 (Affinity Capture-MS), PITRM1 (Affinity Capture-MS), PSMG4 (Affinity Capture-MS), GNPTAB (Affinity Capture-MS), PSMG2 (Affinity Capture-MS), VWA8 (Affinity Capture-MS), LONP1 (Affinity Capture-MS), FAM115C (Affinity Capture-MS), ANKRD40 (Affinity Capture-MS), UBASH3B (Affinity Capture-MS), PSMG3 (Affinity Capture-MS)
ESM2 similar proteins: A0A0U5GHH9, A0A2H4S6M4, A6ZZG1, A7RJ13, B3A0P1, B3A0Q2, C6UYI3, D2K835, G1UB63, J4WMI6, O24006, O84462, O94426, P02674, P04672, P05995, P08672, P08674, P08675, P0DJ88, P0DJ89, P0DRJ4, P11994, P13673, P14328, P18169, P18170, P58454, P83059, P9WG30, P9WG31, Q04433, Q09180, Q23933, Q26264, Q42626, Q42627, Q43402, Q54KD5, Q54M35
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
47 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 39 |
| Likely benign | 8 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1036 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:70156811:G:GT | donor_gain | 0.9900 |
| 4:70158899:AGGTA:A | donor_loss | 0.9900 |
| 4:70158900:GGTA:G | donor_loss | 0.9900 |
| 4:70158902:T:A | donor_loss | 0.9900 |
| 4:70152138:G:GA | donor_loss | 0.9700 |
| 4:70155333:TGGCA:T | donor_gain | 0.9700 |
| 4:70158839:C:G | donor_gain | 0.9700 |
| 4:70152139:T:A | donor_loss | 0.9600 |
| 4:70155334:G:GA | donor_gain | 0.9600 |
| 4:70158901:G:GG | donor_gain | 0.9600 |
| 4:70156052:A:AG | acceptor_gain | 0.9500 |
| 4:70156053:G:GG | acceptor_gain | 0.9500 |
| 4:70158422:A:G | donor_gain | 0.9500 |
| 4:70162805:T:TA | donor_gain | 0.9500 |
| 4:70162806:A:AA | donor_gain | 0.9500 |
| 4:70156053:G:C | acceptor_gain | 0.9300 |
| 4:70152138:G:GG | donor_gain | 0.8900 |
| 4:70155356:GTT:G | donor_gain | 0.8900 |
| 4:70158418:G:GG | donor_gain | 0.8900 |
| 4:70158464:GGT:G | donor_gain | 0.8900 |
| 4:70162693:A:AG | acceptor_gain | 0.8900 |
| 4:70162694:G:GG | acceptor_gain | 0.8900 |
| 4:70158417:A:AG | donor_gain | 0.8800 |
| 4:70158899:AG:A | donor_gain | 0.8800 |
| 4:70158900:GG:G | donor_gain | 0.8800 |
| 4:70162689:TTTCA:T | acceptor_loss | 0.8600 |
| 4:70162690:TTCA:T | acceptor_loss | 0.8600 |
| 4:70162691:TCAGA:T | acceptor_loss | 0.8600 |
| 4:70162692:CAGA:C | acceptor_loss | 0.8600 |
| 4:70162693:AGA:A | acceptor_loss | 0.8600 |
AlphaMissense
1378 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:70154397:T:C | C8R | 0.981 |
| 4:70154391:T:A | W6R | 0.979 |
| 4:70154391:T:C | W6R | 0.979 |
| 4:70158483:G:C | W77C | 0.977 |
| 4:70158483:G:T | W77C | 0.977 |
| 4:70154406:T:C | C11R | 0.973 |
| 4:70154401:T:A | I9N | 0.963 |
| 4:70158481:T:A | W77R | 0.955 |
| 4:70158481:T:C | W77R | 0.955 |
| 4:70154410:T:A | V12D | 0.945 |
| 4:70158529:T:C | F93L | 0.943 |
| 4:70158531:T:A | F93L | 0.943 |
| 4:70158531:T:G | F93L | 0.943 |
| 4:70154413:C:A | A13D | 0.931 |
| 4:70154395:C:A | A7D | 0.930 |
| 4:70154399:C:G | C8W | 0.922 |
| 4:70154415:T:C | F14L | 0.922 |
| 4:70154417:T:A | F14L | 0.922 |
| 4:70154417:T:G | F14L | 0.922 |
| 4:70154398:G:A | C8Y | 0.918 |
| 4:70158485:T:C | I78T | 0.913 |
| 4:70154386:T:A | L4H | 0.912 |
| 4:70154389:T:A | L5H | 0.909 |
| 4:70154404:T:A | V10E | 0.901 |
| 4:70154394:G:C | A7P | 0.897 |
| 4:70158530:T:G | F93C | 0.885 |
| 4:70154381:G:C | K2N | 0.878 |
| 4:70154381:G:T | K2N | 0.878 |
| 4:70158369:T:A | N39K | 0.875 |
| 4:70158369:T:G | N39K | 0.875 |
dbSNP variants (sampled 300 via entrez): RS1000050339 (4:70154703 C>A), RS1000218659 (4:70157538 GA>G), RS1000346997 (4:70163588 A>G), RS1000382811 (4:70163311 C>G,T), RS1000654272 (4:70157357 T>C), RS1000783289 (4:70153347 G>A,C,T), RS1000849262 (4:70154614 G>A), RS1000902576 (4:70158818 C>A,T), RS1001069915 (4:70153021 C>A,G), RS1001167223 (4:70164120 C>T), RS1001480071 (4:70154341 A>C,G), RS1001513866 (4:70164384 T>C), RS1001518110 (4:70154095 T>C), RS10015981 (4:70155719 G>A,C), RS1001671121 (4:70159613 C>A,T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
5 total (human), top 5 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Grape Seed Proanthocyanidins | affects cotreatment, increases expression | 1 |
| Catechin | affects cotreatment, increases expression | 1 |
| Estradiol | decreases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Permethrin | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.